Source: earnings_events
Changes History →Track the stock moves that actually matter.
BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.
Investment research built around change detection.
BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.
What changed: AT&T Inc. 5.35% GLB NTS 66 (TBB) reported EPS of $0.65 vs. consensus estimate of $0.59, beating by 10.2%.
Source: earnings_events
Changes History →Monitor AT&T's next quarterly earnings report and any updates to credit ratings or debt refinancing activity.
What changed: Westinghouse Air Brake Technologies Corporation (WAB) reported EPS of $2.76 vs. consensus estimate of $2.60 for Q2 FY2026, beating consensus by 6.2%.
Source: earnings_events
Changes History →Monitor the company's FY2026 full-year guidance and free cash flow trends in future quarters to assess whether this beat reflects sustainable margin expansion or one-time benefits.
What changed: Philip Morris International Inc. (PM) reported EPS of $2.17 vs. $2.04 consensus estimate for Q2 FY2026, beating by 6.4%.
Source: earnings_events
Changes History →Monitor PM's full-year 2026 guidance and any revisions to consensus estimates in response to the Q2 beat.
What changed: Moody's Corporation (MCO) reported Q2 FY2026 EPS of $4.68 vs. consensus estimate of $4.26, beating by 9.9%.
Source: earnings_events
Changes History →Monitor MCO's full-year 2026 guidance and any updates on revenue trends across its ratings, analytics, and risk assessment divisions.
What changed: Teledyne Technologies Incorporated (TDY) reported EPS of $6.28 vs. consensus estimate of $5.79 for Q2 FY2026, beating consensus by 8.5%.
Source: earnings_events
Changes History →Monitor for management guidance updates on full-year 2026 profitability and any commentary on segment-level performance trends during the earnings call.
What changed: PulteGroup, Inc. (PHM) reported EPS of $2.48 vs. consensus estimate of $2.36, beating by 5.1% for Q2 FY2026.
Source: earnings_events
Changes History →Monitor PHM's full-year 2026 guidance and upcoming quarterly results for sustained profitability trends.
What changed: RPM International Inc. (RPM) reported EPS of $1.89 vs. consensus estimate of $1.83, beating expectations by 3.3% for Q4 FY2026 on July 22, 2026.
Source: earnings_events
Changes History →Monitor RPM's full Q4 FY2026 earnings release for revenue growth, segment performance, and management guidance for FY2027.
What changed: Stifel Financial Corp (SF) reported EPS of $1.42 vs. consensus estimate of $1.33, beating by 6.8% on 2026-07-22.
Source: earnings_events
Changes History →Monitor SF's next earnings report and any management commentary on capital deployment or revenue trends.
What changed: Old National Bancorp (ONB) reported EPS of $0.65 vs. $0.63 consensus estimate for Q2 FY2026, beating by 3.8%.
Source: earnings_events
Changes History →Monitor ONB's next quarterly earnings report and any management guidance on net interest margin and credit quality trends.
Arrowhead Pharmaceuticals surged 24.21% to $92.56 on positive Phase 3 topline results for plozasiran announced July 22. The SHASTA-3 and SHASTA-4 studies showed large triglyceride reductions and fewer acute pancreatitis events versus placebo, per Investing.com. Volume reached 2.76M shares—nearly 6x the time-adjusted average—reflecting elevated investor interest.
ARWR surged 18% to $87.93 following renewed investor attention to the company's pipeline catalysts, particularly around second-half 2026 data readouts and commercialization milestones (web_catalyst). The move also reflects recent bullish analyst coverage, including Stifel's July 14 Buy rating with a $98 price target, combined with a sentiment rebound after a prior pullback.
Regulatory filing timeline for plozasiran and any updates on additional SHASTA study data or label breadth discussions with the FDA.
What changed: Penske Automotive Group surged +10.09% to $214.88, driven by a combination of analyst support and ongoing momentum. Seaport Global Securities maintained a Buy rating on PAG, aligning with the stock's continued climb into the low-$200s this week. The move also reflects market pricing ahead of the previously announced Penske Corp.–Mitsui bid to take the company private at $210 per share (announced July 22, 2026).
Detected Jul 22, 3:30 PM ET
Changes History →PAG's Q2 2026 earnings on July 29, 2026, and any updates on the Penske Corp.–Mitsui take-private transaction process, including competing bids or regulatory approvals.
Latest research
View all research →In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.

Why did Danaher (DHR) stock fall ~13% on July 21, 2026 — a beat-and-raise undone by a core revenue guidance cut
Danaher fell nearly 13% on July 21, 2026 despite beating on adjusted EPS and raising its full-year earnings guidance. The company tied that raise partly to completing the Masimo acquisition early — while cutting full-year core revenue growth guidance to 3–4% from 3–6% and marking bioprocessing down to mid-single-digit growth. The market paid for the organic line, not the inorganic one. Bioprocessing peers Repligen and Sartorius fell in sympathy while instrument makers rose, on a day the broad market was up ~1%.
Why did Hut 8 (HUT) stock jump ~11% on July 20, 2026 — a second $9.8 billion Beacon Point lease that fully commercializes a 1 GW campus
Hut 8 jumped about 11% on July 20, 2026 after a second 352 MW, 15-year, $9.8 billion lease fully commercialized its 1 GW Beacon Point campus in Texas — signed by the same unnamed tenant that took Phase 1 in May. The deeper significance is financing: Phase 1 was funded with $4.25 billion of non-recourse, Baa2-rated notes, and an anchor lease is the precondition for repeating that. But the move only round-trips a two-session drop, leaving the stock below where it closed on Wednesday.

Why did Alcoa (AA) stock fall ~6% on July 17, 2026 — a record Q2 that still missed, and an alumina guidance cut
Alcoa closed down 6.1% on July 17, 2026 — far more than its aluminum peers or the metal itself. Its Q2 set a revenue record and grew adjusted EPS more than fivefold, but it missed an elevated Street bar and cut full-year alumina guidance after cyclone-related outages at its Pinjarra refinery. The drop confirmed an aluminum-surplus bear case analysts had already been pricing in, and it layers dilution and integration questions from the pending South32 acquisition on top.

Why did Cadence Design Systems (CDNS) stock fall ~10% on July 17, 2026 — Kimi K3 and the EDA selloff?
Cadence fell about 10% intraday on July 17, 2026 — far more than the broad chip group, which pared its morning losses. Market coverage tied the EDA pair's underperformance to Moonshot's Kimi K3, which the company says designed a 45nm chip in simulation using only open-source tools. It's an early, reported proof of concept, set against a broad semiconductor retreat — and it overwhelmed Cadence's own Rapidus AI partnership and Benchmark's $450 Buy call.

Why did Intuitive Surgical (ISRG) stock plunge ~13% on July 17, 2026 — despite a Q2 earnings beat?
Intuitive Surgical dropped about 13% intraday to a fresh 52-week low the morning after beating Q2 estimates. The catalyst was the outlook, not the quarter: full-year da Vinci procedure-growth guidance of 13.5–15.5% implies a second-half deceleration, with moderating U.S. demand and an ACA coverage headwind. A ~40x multiple left no room for it, and six firms cut targets within hours — while the rest of medtech barely moved.

Why did Bloom Energy (BE) stock plunge ~14% on July 16, 2026 — despite a $1.7B AI-power deal?
Bloom Energy dropped about 14% intraday on the same day IDF and Oaktree announced a $1.7 billion project financing to power Nebius's AI build-out. The move reads as 'sell the news' — profit-taking on a stock priced north of 250x EV/EBITDA, a fuel-cell-complex derating (FCEL −16%), and a broad AI-capex risk-off — with a thinly-detailed deal and the prior week's short-seller overhang in the background.











